Physician profile
Peter Higgins
NPI 1659528974
$1,162.83
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $462 · 2022: $570 · 2023: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $372.81 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $148.35 | 2022-2023 | Quviviq |
| Novo Nordisk INC | $114.17 | 2022 | |
| Merck Sharp & Dohme LLC | $109.70 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $71.77 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $52.12 | 2022 | |
| Bausch Health US, LLC | $45.33 | 2021-2022 | |
| Almatica Pharma LLC | $44.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.71 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $34.32 | 2021-2022 | |
| Eisai INC. | $28.69 | 2021 | |
| Lilly USA, LLC | $27.75 | 2021 | |
| Abbott Laboratories | $16.63 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.43 | 2022 | |
| Philips North America LLC | $15.00 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $14.30 | 2021 | |
| Glaxosmithkline, LLC. | $13.75 | 2023 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.